Rishabh Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.25 M
as on 23-06-2024
- Paid Up Capital ₹ 4.25 M
as on 23-06-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 7.50 M
as on 23-06-2024
- Revenue 128.10%
(FY 2020)
- Profit -256.32%
(FY 2020)
- Ebitda -29.48%
(FY 2020)
- Net Worth -5.80%
(FY 2020)
- Total Assets 11.01%
(FY 2020)
About Rishabh Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.25 M and a paid-up capital of Rs 4.25 M.
The company currently has active open charges totaling ₹7.50 M.
Jhumar Dugar, Pushpadevi Dugar, and Daxaben Satani serve as directors at the Company.
- CIN/LLPIN
U01132GJ2014PTC078793
- Company No.
078793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2014
- Date of AGM
27 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rishabh Biotech Private Limited offer?
Rishabh Biotech Private Limited offers a wide range of products and services, including Organic Fertilizers and Manure, Fulvic Acid, Fertilizer, Amino Acids, Micronutrient, Potassium Humate, Herbicides, Plant Growth Promoters, Zyme Granules and Liquid, Soil Conditioner.
Who are the key members and board of directors at Rishabh Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jhumar Dugar  | Director | Current | |
| Pushpadevi Dugar | Director | 18-Feb-2014 | Current |
| Daxaben Satani | Director | 06-Jan-2020 | Current |
Financial Performance of Rishabh Biotech.
Rishabh Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 128.1% increase. The company also saw a substantial fall in profitability, with a 256.32% decrease in profit. The company's net worth dipped by a decrease of 5.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rishabh Biotech?
In 2020, Rishabh Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rishabh Colours Private LimitedActive 20 years 6 monthsJhumar Dugar and Pushpadevi Dugar are mutual person
- Jmj Impex Private LimitedActive 14 years 6 months
Jhumar Dugar and Pushpadevi Dugar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Jun 2014 | ₹7.50 M | Open |
How Many Employees Work at Rishabh Biotech?
Unlock and access historical data on people associated with Rishabh Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rishabh Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishabh Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
